Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.

Peake DA, Ackermann BL.

J Am Soc Mass Spectrom. 2005 Apr;16(4):599-605. No abstract available.

PMID:
15871168
2.

Results from a bench marking survey on cassette dosing practices in the pharmaceutical industry.

Ackermann BL.

J Am Soc Mass Spectrom. 2004 Sep;15(9):1374-7. No abstract available.

3.

Large-scale oxidations in the pharmaceutical industry.

Caron S, Dugger RW, Ruggeri SG, Ragan JA, Ripin DH.

Chem Rev. 2006 Jul;106(7):2943-89. Review. No abstract available.

PMID:
16836305
4.

High-throughput and parallel screening methods in asymmetric hydrogenation.

Jäkel C, Paciello R.

Chem Rev. 2006 Jul;106(7):2912-42. Review. No abstract available.

PMID:
16836304
5.

Multicomponent reactions in solid-phase synthesis.

Banfi L, Guanti G, Riva R, Basso A.

Curr Opin Drug Discov Devel. 2007 Nov;10(6):704-14. Review.

PMID:
17987522
6.

Analysis of the reactions used for the preparation of drug candidate molecules.

Carey JS, Laffan D, Thomson C, Williams MT.

Org Biomol Chem. 2006 Jun 21;4(12):2337-47. Epub 2006 May 3. Review.

PMID:
16763676
7.

Organic synthesis in flow for medicinal chemistry.

Wirth T.

Bioorg Med Chem. 2017 Dec 1;25(23):6179. doi: 10.1016/j.bmc.2017.11.013. No abstract available.

PMID:
29153554
8.

Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.

Rubin AE, Tummala S, Both DA, Wang C, Delaney EJ.

Chem Rev. 2006 Jul;106(7):2794-810. Review. No abstract available.

PMID:
16836299
9.

Controlling chirality in enzymatic synthesis.

Hodgson J.

Biotechnology (N Y). 1992 Oct;10(10):1093-7. No abstract available.

PMID:
1368788
10.

Palladium coupling catalysts for pharmaceutical applications.

Doucet H, Hierso JC.

Curr Opin Drug Discov Devel. 2007 Nov;10(6):672-90. Review.

PMID:
17987520
11.

Assessment of structural diversity in combinatorial synthesis.

Fergus S, Bender A, Spring DR.

Curr Opin Chem Biol. 2005 Jun;9(3):304-9. Review.

PMID:
15939333
12.

Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges.

Douroumis D, Nokhodchi A.

Adv Drug Deliv Rev. 2017 Aug 1;117:1-2. doi: 10.1016/j.addr.2017.10.002. No abstract available.

PMID:
29103527
13.

Current and future impact of green chemistry on the pharmaceutical industry.

Fortunak JM.

Future Med Chem. 2009 Jul;1(4):571-5. doi: 10.4155/fmc.09.60. No abstract available.

14.

The impact of microwave synthesis on drug discovery.

Kappe CO, Dallinger D.

Nat Rev Drug Discov. 2006 Jan;5(1):51-63. Review.

PMID:
16374514
15.

Forewords BMC.

Gallou F.

Bioorg Med Chem. 2018 Aug 7;26(14):4329. doi: 10.1016/j.bmc.2018.06.041. Epub 2018 Jul 3. No abstract available.

PMID:
29983282
16.

Drug industry looks to the lab instead of rainforest and reef.

Service RF.

Science. 1999 Jul 9;285(5425):186. No abstract available.

PMID:
10428712
17.

Asymmetric synthesis of active pharmaceutical ingredients.

Farina V, Reeves JT, Senanayake CH, Song JJ.

Chem Rev. 2006 Jul;106(7):2734-93. Review. No abstract available.

PMID:
16836298
18.

Greener pharmaceuticals.

Clark JH, Breeden SW, Summerton L.

Future Med Chem. 2009 Jun;1(3):409-13. doi: 10.4155/fmc.09.46. No abstract available.

PMID:
21426120
19.

Chemical library synthesis using convergent approaches.

Beeler AB, Schaus SE, Porco JA Jr.

Curr Opin Chem Biol. 2005 Jun;9(3):277-84. Review.

PMID:
15939329
20.

Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.

Muñoz Solano D, Hoyos P, Hernáiz MJ, Alcántara AR, Sánchez-Montero JM.

Bioresour Technol. 2012 Jul;115:196-207. doi: 10.1016/j.biortech.2011.11.131. Epub 2011 Dec 14. Review.

PMID:
22230779

Supplemental Content

Support Center